Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient.

Pure red cell aplasia caused by parvovirus B19 in a heart transplant recipient

A case of parvovirus B19-induced pure red cell aplasia occurring in a heart transplant recipient is reported. The diagnosis of this rare but clinically important complication can be suspected on the basis of the pathognomonic morphological features of the bone marrow.

Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast

A case of pure red cell aplasia in a simultaneous kidney-pancreas transplant recipient on immunosuppressive therapy is reported here. The patient presented with anemia unresponsive to erythropoietin treatment. Bone marrow cytomorphology was highly suggestive of parvovirus pure red cell aplasia, which was confirmed with serology and polymerase chain reaction positive for parvovirus B19 DNA in pe...

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.

Transplant recipients are known to be susceptible to primary viral infections or to reactivation of a persistent virus. Most of the clinically relevant infections are caused by the herpes-viridae group (CMV, EBV, VZV, HSV I and II). Human parvovirus B19 was first discovered 1975 in human packed blood [1] and subsequently shown to cause fifth disease or erythema infectiosum in children [2]. The ...

Parvovirus B19–induced pure red cell aplasia in a heart transplant recipient.

A 29-year-old female presented with unexplained anemia (hemoglobin 77 g/L) 5 years after orthoptic heart transplantation. She was being treated with high-dose immunosuppression. The blood film demonstrated a normochromic normocytic anemia. The white cell and platelet counts were normal. There was reticulocytopenia (1 109/L, 0.04%) and an elevated erythropoietin (356 U/mL; normal, 5-18.5 U/mL) w...

A patient with pure red cell aplasia after allogenic stem-cell transplantation. Parvo B19 infection.